With more than 80 experts, Cleveland Clinic Cancer Center’s Rare Cancers and Blood Diseases Initiative provides advanced care and access to clinical trials for patients with novel malignancies.
A 68-year-old man presents with dyspnea on exertion. What caused his left-sided pleural effusion?
A new study shows that physicians may be overtreating patients with well-differentiated thyroid cancer and putting them at risk for more deadly diseases.
As part of efforts to reduce 30-day unplanned readmissions, Cleveland Clinic has instituted five-day follow-up for all cancer patients discharged after hospitalization.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Cleveland Clinic researchers are first to test eltrombopag during 7+3 induction chemotherapy in AML. Interim data suggest eltrombopag can accelerate platelet recovery and potentially reduce the need for platelet transfusions.
Cleveland Clinic researchers find that thyroid cancer patients treated with surgery and radioactive iodine +/- external beam radiotherapy have an increased risk of MDS after two years.